Since IL-18 mRNA and IL-18 protein were detected in primary ovarian cell cultures, it is reasonable to assume that the elevated IL-18 levels in ovarian cancer patient sera are produced by ovarian carcinoma cells as well as tumor-activated immune cells [19]. Here, IL18 is linked to ovarian cancer.